fda

Sector Update: Health Care - January 7, 2011

Published on Fri, 01/07/2011 - 15:27
By Stephanie Shyu in General Interest, NVS, PFE, rpc, cancer, court, drug maker, fda, health, kit, lawsuit, medicine, novartis, nvs, patent, pfe, pfizer, pharma, radient, rpc, sector, shares, vfend
cancer, court, drug maker, fda, health, kit, lawsuit, medicine, novartis, nvs, patent, pfe, pfizer, pharma, radient, rpc, sector, shares, vfend

Health care shares are down in mid-day trading as Pfizer (PFE) lobs a patent infringement lawsuit against a Novartis (NVS) unit in Delaware. In mid-day news, shares of Pfizer are just higher after the drug maker sued Novartis Sand

By Stephanie Shyu
sshyu@fnno.com

Regeneron Pharmaceuticals Dips; Development of Pain Killer Halted

Published on Mon, 12/27/2010 - 11:15
By FNN Staff in General Interest, REGN, sny, analysis, fda, financial, market, regeneron pharmaceuticals, regn, sanofi-aventis, sny, stock, trading

Sanofi-Aventis is trading at $32.09, down 41 cents, or 1.26%.

analysis, fda, financial, market, regeneron pharmaceuticals, regn, sanofi-aventis, sny, stock, trading

Regeneron Pharmaceuticals (REGN) is just lower after it said in a SEC filing U.S. regulators halted development of an experimental pain killer it's developing with Sanofi-Aventis SA (SNY) after a similar treatment caused the death

By FNN Staff
root@fnn-online.com

Cumberland Pharmaceuticals Down 11%; FDA Study Doesn't Show

Published on Wed, 12/22/2010 - 12:42
By FNN Staff in analysis, CPIX, cumberland pharmaceuticals, fda, financial, market, stock, trading
cumberland pharmaceuticals, cpix, fda, stock, trading, market, analysis, financial

By FNN Staff
root@fnn-online.com

Arena Pharma Ends Meeting With FDA, to Resubmit Lorcaserin N

Published on Wed, 12/22/2010 - 09:01
By FNN Staff in General Interest, arna, analysis, arena pharmaceuticals, arna, fda, financial, market, stock, trading

Arena's President and Chief Executive Officer Jack Lief said, "The meeting discussions reinforce our position that we have a path forward to seek FDA approval of lorcaserin. Based on guidance we have received from the agency, we a

analysis, arena pharmaceuticals, arna, fda, financial, market, stock, trading

Arena Pharmaceuticals (ARNA) and Eisai Inc. announced the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).

By FNN Staff
root@fnn-online.com

AstraZeneca to Take $445M Charge in Q4

Published on Tue, 12/21/2010 - 08:27
By FNN Staff in General Interest, AZN, analysis, astrazeneca, azn, fda, financial, market, stock, trading
analysis, astrazeneca, azn, fda, financial, market, stock, trading

Officials from AstraZeneca (NYSE:AZN) said in a statement Tuesday that the company has requested that the U.S. Food and Drug Administration withdraw its application for the approval of its motavizumab drug, used to treat respirato

By FNN Staff
root@fnn-online.com

FDA Grills AstraZeneca for More Brilinta Drug Data Before Ap

Published on Fri, 12/17/2010 - 08:41
By FNN Staff in General Interest, AZN, analysis, astrazeneca, azn, brilinta, fda, financial, market, pharamceutical, stock, trading
analysis, astrazeneca, azn, brilinta, fda, financial, market, pharamceutical, stock, trading

Officials from AstraZeneca PLC (NYSE:AZN) said that the U.S. Food and Drug Administration is asking for additional data from the firm's study of Brilinta. Brilinta is a new heart drug from AstraZeneca, which the FDA will not appro

By FNN Staff
root@fnn-online.com

What's In The News: December 17th, 2010

Published on Fri, 12/17/2010 - 08:23
By FNN Staff in General Interest, ANR, AZN, GM, ICO, MEE, alpha natural resources, analysis, anr, astrazeneca, azn, fda, federal reserve, financial, general motors, gm, ico, international coal, market, massey energy, mee, nhtsa, stock, trading
alpha natural resources, analysis, anr, astrazeneca, azn, fda, federal reserve, financial, general motors, gm, ico, international coal, market, massey energy, mee, nhtsa, stock, trading

This is what's in the news for Friday, December 17th. the Wall Street Journal is reporting that the FDA has delayed approval for Brilinta - AstraZeneca's (AZN) new heart drug - and said it wants more information about a key study.

By FNN Staff
root@fnn-online.com

Johnson & Johnson Over-the-Counter Drug Plant Cited for FDA

Published on Thu, 12/16/2010 - 15:22
By FNN Staff in General Interest, JNJ, counter, drug, fda, health, inspection, jnj, johnson, over, plant, shares, violation
johnson, jnj, shares, health, violation, drug, over, counter, plant, fda, inspection

Johnson & Johnson (JNJ) shares are down after a Bloomberg report that U.S. health regulators cited the company for violations at one of its plants, where it stopped making over-the-counter drugs earlier this year. Staff from

By FNN Staff
root@fnn-online.com

Bionovo Jumps 19%, Agrees With FDA on Plan for Menerba

Published on Mon, 12/13/2010 - 09:54
By Anonymous in bionovo, bnvi, fda, financial news network, fnn, fnno, stock market
bionovo, fda, bnvi, stock market, fnn, financial news network, fnno

By Anonymous

EpiCept Surging 40% Pre-Market on New Analysis of Ceplene's

Published on Fri, 12/10/2010 - 09:39
By Anonymous in acute, aml, analysis, cancer, ceplene, clinical, drug, epct, epicept, eu, fda, fnn, leukemia, myeloid, patient, premarket, remission, survival, trial
epicept, epct, analysis, ceplene, survival, eu, remission, patient, acute, myeloid, leukemia, aml, cancer, fda, drug, clinical, trial, premarket, fnn

By Anonymous

Latest News from FNNO

Arbitron Earnings In Retrospect: Up 0.0%...

18 days ago, on May 7th, 2013, Arbitron (NYSE:ARB) reported its earnings. Analysts, on ...

Chiquita Brands International Earnings I...

Two weeks ago on May 7th, 2013 Chiquita Brands International (NYSE:CQB) reported earnin ...

The Williams Cos Earnings Review: 18 Day...

When The Williams Cos (NYSE:WMB) reported earnings 18 days ago on May 7th, 2013, analys ...

Granite Construction Earnings Review: 16...

When Granite Construction (NYSE:GVA) reported earnings 16 days ago on May 9th, 2013, an ...

Earnings Flashback: Since Reporting Quar...

Two weeks ago on May 7th, 2013 DaVita (NYSE:DVA) reported earnings and analysts, on ave ...

Earnings Look Back: ProAssurance Is Up 2...

19 days ago, on May 6th, 2013, ProAssurance (NYSE:PRA) reported its earnings. Analysts ...

Post Earnings Update: Apache Has Climbed...

Two weeks ago on May 9th, 2013 Apache (NYSE:APA) reported earnings and analysts, on ave ...

Global Cash Access Holdings Earnings In ...

When Global Cash Access Holdings (NYSE:GCA) reported earnings two weeks ago on May 7th, ...

Most Popular Video News

  •
    01:10 PM MIDWEEK MARKET WRAP UP:New Report Expected to Shakeup Libor

    From FNNO.com, this is the Financial News Network. I’m Cleo
    Stiller-Farrell and this is your Midweek Market Wrap Up. The British
    Bankers’ Association, which has the supervisory role of setting the
    influential Libor rates, announced that it would be willing to give up
    its...

    +
  • 11:04 AM What's in the News for September 26, 2012

    The Wall Street Journal reports that home prices showed their best year-to-date gains since 2005, up 5.9% through July, signaling the housing market's steady march toward recovery. Also from the Wall Street Journal, IBM (IBM) will increase its efforts to sell so-called cloud computing services...

    +
  • 11:04 AM Yahoo Makes Ken Goldman New CFO

    CEO Marissa Mayer is bringing in some more new blood to Yahoo!, tapping Ken Goldman as the company's new Chief Financial Officer. Goldman's appointment will take effect on October 22nd.

    Goldman served as CFO at his most recent employer, Fortinet, having worked at Siebel Systems, Sybase,...

    +
More